Furthermore, the oxytocin receptor (OXTR) have been shown to interact with the ghrelin receptor (GHSR), suggesting that ghrelin-targeted therapy may be able to control oxytocin signaling associated with schizophrenia [119]. This evidence concerns the gene OXT and schizophrenia.